ILCA Africa Programme and Fellowship 2022
We are proud to focus this year ILCA Fellowship on supporting research with projects in Africa with a topic relevant for African patients.
ILCA is ramping up efforts to alleviate Africa’s need for medical assistance. Although the African continent is one of the regions with a very high disease burden, clinical and scientific resources for diagnosing, treating, and researching liver cancer are very limited in most parts of this continent. ILCA recognises this immense clinical and scientific need and plans to develop a strategy to engage African organisations and healthcare professionals in educational and training activities of ILCA.
Together with Dr. Lewis Roberts, ILCA Ambassador for Africa, we are launching for this year the ILCA Africa Fellowship 2022 linked to the ILCA Africa Programme.
ILCA Fellowship 2022/2023 Awardee
Congratulations to the ILCA Fellowship 2022/2023 Awardee!
ILCA is pleased to announce that Marko Zaki, Postdoctoral Research Fellow from Minia University, Minia, Egypt, has been awarded the ILCA Fellowship 2022/2023.
ILCA will support his research on “TP53 and the anti-tumour immunity; the role of TP53 downstream target PSRC1 in switching the “cold” tumours into “hot” ”. The ultimate goal of this project is
1-Immunophenotyping of the HCC cohort to link PSRC1 tissue expression, with its related secretome, with the immune, infiltrate within the tumour.
2-Functional characterisation of PSRC1-mediated immune cell recruitment in HCC.
3-In-depth study of the mechanisticand immunomodulatoryfunctions of PSRC1 downstream of TP53 mutation.
ILCA Fellowship 2021 Awardee
Congratulations to the ILCA Fellowship 2021 Awardee!
ILCA is pleased to announce that Benjamin Ruf, Postdoctoral Research Fellow from the National Institutes of Health (NIH), National Cancer Institute (NCI), USA, has been awarded the ILCA Fellowship 2021.
ILCA will support his research on “Elucidating the role of mucosal-associated invariant T cells (MAITs) in hepatocellular carcinoma (HCC) using spatial transcriptomic analysis by combining CODEX and single-cell RNA-sequencing”. The ultimate goal of this project is to understand the function of these cells and then develop MAIT-directed therapies to treat patients with liver cancer.
Discover a bit more about our ILCA Fellowship 2021 awardee
Stay tuned for future ILCA Fellowship Programmes available!
ILCA Fellowship 2020 Awardee
Congratulations to the ILCA Fellowship 2020 Awardee!
ILCA is pleased to announce that Aveline Filliol, Postdoctoral Research Scientist from the Columbia University, USA, has been awarded the ILCA Fellowship 2020.
ILCA will support her research on “Deciphering the role of hepatic stellate cell-derived myofibroblasts in hepatocellular carcinoma”. Aveline Filliol will be working on determining the role of hepatic stellate cell-derived myofibroblasts in the development of hepatocellular carcinoma.
Discover a bit more about our ILCA Fellowship 2020 awardee
Through the Fellowship Programme, ILCA supports research in all liver cancer-related disciplines by encouraging young Scientifics to develop their career in liver cancer research. This year ILCA Fellowship Programme 2020 is supported by an Educational Grant from:
Stay tuned for future ILCA Fellowship Programmes available!
ILCA Fellowship 2019 Awardee
Congratulations to the ILCA Fellowship 2019 Awardee!
ILCA is pleased to announce that Dr. Jin Lee, from the Department of Pathology of the School of Medicine, University of California, San Diego, was awarded the ILCA Fellowship 2019.
ILCA will support her research on Immunotherapeutic Target on Unique Mitotic Spindle in Hepatocellular Carcinoma.
Can you please tell us a bit about your research project?
Despite microtubule-binding compound being widely used as a chemotherapeutic in the treatment of various cancers, it has shown disappointing results in liver cancer, since it extensively affects normal cells. Specifically targeting mitosis in cancer cells is considered as a preferred strategy. For this purpose, I am working on study to know whether immune cells can target specifically proliferating cancer cells through unique mitosis machinery and what mechanism they have.
For my objectives, I will successfully complete this project with a goal to discover a novel target of HCC and propose a new therapeutic strategy for treatment humans with HCC. I hope this work will contribute in clinic finally.
Why did you get involved in this type of research?
There is nothing nicer than knowing. My pleasure was to discover the undiscovered things and this led me to do basic science research. So far human beings have been suffering from many types of cancer. I believed in basic science is fundamentally essential to the study of the medicine and it is the key of the drug discovery especially for cancer. For this reason, I did get involved in cell biology research and want to know about how tumour cells communicate with other type of cells in tumour microenvironment.
How will the ILCA grant help you?
I am so grateful that ILCA will support my research. It is an honor to receive this prestigious fellowship. The ILCA grant will encourage me to pursue science and to increase self-motivation. It will be a milestone for the next chapter of my career as an independent scientist.
ILCA Fellowship 2018 Awardee
Congratulations to the ILCA Fellowship 2018 Awardee!
ILCA is pleased to announce that Dr. Stefanie Hectors, from the Icahn School of Medicine at Mount Sinai, was awarded the ILCA Fellowship 2018.
ILCA is supporting her research on Quantitative MRI for Noninvasive Prediction of Gene Signatures in Hepatocellular Carcinoma.